I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

In neurosurgical patients, goals of anesthesia include the maintenance of adequate cerebral oxygenation, cerebral perfusion pressure (CPP), stable hemodynamics, and relaxed brain to facilitate surgical procedures.\[[@ref1]\] Among several inhalational and intravenous agents, propofol is presently being preferred over other drugs for the maintenance of anesthesia in neurosurgical patients. Although it produces dose-dependent decrease in both cerebral blood flow and cerebral metabolic rate of oxygen, it causes hypotension, especially in hypovolemic patients, thus affecting perfusion and oxygenation of the brain.\[[@ref2]\] On the other hand, despite several advantages have been attributed to ketamine, it is not frequently used as an anesthetic agent of choice because of its sympathomimetic effects.\[[@ref3]\]

Since propofol causes dose-dependent hypotension and ketamine prevents hypotension by its sympathomimetic effect, it was postulated that combination of both the drugs will result in a mixture (termed as ketofol) which will have additive effects, so that the dose of individual drug can be decreased and benefit of both the drugs such as amnesia, analgesia, hypnosis, and hemodynamic stability can be achieved.\[[@ref4]\]

Cerebral oxygenation can be indirectly assessed by jugular venous oxygen saturation (SjVO~2~), which reflects the global cerebral balance between oxygen demand and supply.\[[@ref5]\] The SjVO~2~ monitoring during the perioperative period helps in guiding oxygenation, hyperventilation therapy, and optimizing perfusion pressure. It provides an early diagnosis of cerebral ischemia resulting from either intracranial or systemic causes.\[[@ref6][@ref7]\]

Although numerous studies have been published on the effects of ketofol on hemodynamics and opioid consumption intraoperatively, there is a lack of evidence on its effects on cerebral oxygenation. Hence, in the present study, the primary aim was to compare the effects of ketofol with propofol alone on cerebral oxygenation using SjVO~2~, in patients undergoing surgical clipping of intracranial aneurysm. We chose patients of aneurysmal clipping with the objective that the maintenance of CPP and oxygenation is the pivotal aim during the intraoperative period. We hypothesize that the ketofol may achieve the aim of maintaining adequate CPP and oxygenation though a better balance between MAP and intracranial pressure (ICP) as compared to propofol alone.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

After approval from the Institutional Ethical Committee and written informed consent from the patient or next of kin, this prospective randomized study was conducted in patients undergoing aneurysmal clipping following spontaneous rupture of intracranial aneurysm. American Society of Anesthesiologists IE/IIE, between the age group of 18 and 65 years, Hunt and Hess (H and H) Grade I--II, World Federation of Neurosurgeons (WFNS) Grade I--II patients were included in the study. Patients with a diameter of aneurysm \>25 mm, known coronary artery disease, psychiatric disease, and poor-grade aneurysm (H and H IV--V, WFNS IV--V) were excluded from the study.

Forty patients were randomized into ketofol (KP) (*n* = 20) and propofol (P) (*n* = 20) groups using computer-generated random tables, and concealment was done using opaque sealed envelope method. Doubleblindedness was ensured as neither the investigator nor the patient knew of the drug being administered. The sample size of total 40 patients was calculated with an α error of 0.05, and the power of the study was 80% considering SjVO~2~ values \<50% as significant cerebral hypoperfusion based on the previous study.\[[@ref8]\] The patients in propofol group received propofol as maintenance agent, and the patients in ketofol group received combination of ketamine and propofol in a ratio of 1:5 for the maintenance of anesthesia.

Initially, few pilot cases were done using incremental concentrations of ketamine from 1:6--1:3 with propofol. Ketamine-propofol combination in a ratio of 1:5 was chosen to be used, as it provided better hemodynamic stability as well as reduced airway secretions when compared with other concentrations used.

The study drug was prepared in a 50 mL syringe, 48 ml of propofol (10 mg.mL^-1^) was loaded in the propofol (P) group, and for ketofol group (KP), 40 mL of propofol and 8 ml of ketamine (10 mg.mL^-1^) were added by an anesthesiologist who was not directly involved in the study to ensure double-blindedness. Thus, 1 ml of ketofol contained propofol 8.3 mg and ketamine 1.7 mg. These study drug infusions were used only for the maintenance of anesthesia after the measurement of baseline SjVO~2~.

A standard anesthesia protocol was followed for the induction of anesthesia. Patients in both the groups were induced with thiopentone (4--6 mg.kg^-1^) with the dose titrated to loss of eyelash response and intubated after the administration of vecuronium (0.1 mg.kg^-1^). Fentanyl was administered in a dose of 2 μg.kg^-1^ followed by 1 μg.kg^-1^ as infusion for intraoperative analgesia. Lignocaine 1.5 mg.kg^-1^ was administered before laryngoscopy to attenuate the hemodynamic stress response. PaCO~2~ was kept between 32 and 35 mmHg; ventilation was maintained with 50% oxygen and air in all the patients.

For beat-to-beat monitoring of blood pressure and blood gas analysis, an arterial catheter was placed in the radial artery before the induction of anesthesia. Patients were monitored for heart rate (H), mean arterial pressure (MAP), pulse oximetry (SpO~2~), end-tidal carbon dioxide, neuromuscular monitoring, temperature, pulse pressure variation, and systolic pressure variation along with urine output. The patients were maintained with sevoflurane till the insertion of SjVO~2~ catheter.

Jugular bulb oximetry was done using a single-lumen 5 Fr, 20 cm long central venous catheter under ultrasound guidance was inserted on the side of aneurysm using the standard puncture as for internal jugular venous cannulation but in the retrograde direction. The catheter was inserted by Seldinger\'s technique. Confirmation of correct placement was done using C-arm by the skull and neck radiography. The tip should lie at the C1-C2 level or at the level of mastoid, just medial to it for appropriate sampling. The blood samples were withdrawn slowly at a rate of not ≥2 ml/min to avoid extracerebral contamination. Baseline samples were taken immediately after the insertion of catheter. After the baseline sampling, sevoflurane was turned off, and anesthesia was maintained with study drug infusion at 0.3 mL.kg^-1^.h^-1^. Further, sampling of jugular bulb blood was done every hourly after the starting of the test drug till the end of the surgery, followed by 6 h after the stopping of drug.

The study drug infusion was titrated to maintain hemodynamic stability throughout the period of surgery. Hemodynamic parameters such as H and MAP were recorded at different time periods such as preinduction, baseline value (before the start of study drug), after pin insertion, during making burr hole, at starting of craniotomy, at bone flap removal, at opening of dura mater, during temporary clipping, during permanent clipping of aneurysm, at dural closure, at muscle suturing, at skin closure, at extubation, and 6 h after completion of surgery.

Whenever MAP fell to \<20% of the baseline value, an intravenous fluid bolus of 200 ml was infused, and the study drug infusion was decreased by 10%. If hypotension still continued, boluses of phenylephrine 50 μg were administered at an interval of 5 min. If hypotension persisted even after three consecutive phenylephrine boluses, then nor adrenaline infusion was started at the rate of 0.1 μg.kg^-1^.min^-1^. If MAP increased \>20% of the baseline value, the study drug infusion was increased by 10%. If hypertension continued, then boluses of esmolol 0.5--1 mg.kg^-1^ IV over 30 s were given and repeated at 5-min interval. The number of boluses of rescue drugs and total dose of rescue drugs used were noted.

Brain relaxation was assessed on a grading system after craniotomy before the opening of dura mater by the blinded operating neurosurgeon who had at least 5 years of experience. Brain condition was assessed by a four grade scales: Grade 1 -- brain surface lies below the surface of craniotomy margin and well retracted into the cranial cavity with good brain pulsations, Grade 2 -- brain surface lies just below the surface of craniotomy region margin and brain pulsations are well seen, Grade 3 -- brain surface lies at the level of craniotomy margins and brain pulsations are observed faintly, and Grade 4 -- the brain surface is jutting out or expanding beyond the craniotomy margin and brain pulsation are not clearly defined.\[[@ref9]\]

Fentanyl infusion was stopped at the beginning of scalp closure, whereas anesthetic agents were stopped after the removal of headpins. Patients were shifted to the neurosurgical intensive care unit (ICU) for further neurocritical care. Total duration of anesthesia (from induction to stoppage of drug infusions) and total duration of surgery (from incision to last skin suture) were also noted.

Statistical analysis {#sec2-1}
--------------------

Statistical analysis was carried out using the Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL, USA, version 21.0). The continuous data were presented as a mean ± standard deviation for normally distributed data; two groups were compared using the Student\'s *t*-test. Categorical and nominal data were described as proportions, and Chi-square test or Fisher\'s exact test was used to look at significant associations. Paired sample *t*-test was also used for baseline comparison. *P* \< 0.05 was considered statistically significant.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

The patient characteristics were comparable in both the groups \[[Table 1](#T1){ref-type="table"}\]. All the values of SjVO~2~ in both the groups were within the normal limits (50%--70%). Higher values of SjVO~2~ were observed in ketofol group compared to propofol group at 1 and 2 h after starting of the study drug, and at 6 h after surgery which was statistically significant (*P* \< 0.05). In the propofol group, a statistically significant fall in SjVO~2~ was recorded at 2 h after the starting of the study drug as compared to the baseline (*P* = 0.001), whereas in ketofol group, all the recordings were compared with baseline (*P* \> 0.05) \[[Table 2](#T2){ref-type="table"}\].

###### 

Patient demographics

  Parameters                        KP (*n*=20)   P (*n*=20)     *P*
  --------------------------------- ------------- -------------- ----------
  Age (year)                        48.05±8.287   49.25±12.523   0.723^β^
  Sex (male/female)                 10/10         12/8           0.404^π^
  Weight                            68.15±4.715   70.25±6.356    0.076^β^
  ASA Grade IE/IIE                  6/14          7/13           
  Site of ruptured aneurysm ACOM/   6/5/1/3/2/3   6/5/2/2/3/2    
  MCA/ACA/PCOM/ICA/DACA                                          
  Hunt and Hess (1/2)               17/3          16/4           0.453^π^
  WFNS (1/2)                        5/15          5/15           1.000^π^
  Baseline hemoglobin               11.04±2.10    11.67±2.24     0.364

^π^Variables analyzed by Fisher's exact test, ^β^Variables analyzed by independent *t*-test, *P*\<0.05 was considered as statistically significant. ASA=American Society of Anesthesiologist, ACOM=Anterior communicating artery, MCA=Middle cerebral artery, ACA=Anterior cerebral artery, PCOM=Posterior communicating artery, ICA=Internal carotid artery, DACA=Distal anterior cerebral artery, WFNS=World Federation of Neurosurgeon, KP=Ketofol, P=Propofol

###### 

Jugular venous oximetry parameters

                       SjVO~2~                   
  -------------------- ------------ ------------ ---------
  Baseline             65.13±2.40   63.80±3.44   0.164
  At 1 h               65.56±2.98   62.58±3.35   0.005\*
  At 2 h               63.61±3.50   60.41±3.48   0.006\*
  At 6 h postsurgery   64.78±1.65   63.05±3.16   0.036\*

\**P* value \< 0.05 is considered significant. SjVO~2~=Jugular venous oximetry, KP=Ketofol, P=Propofol

Brain relaxation scores were comparable in both the study groups (*P* = 0.887). Brain relaxation in ketofol group was as good as that of propofol group \[[Table 3](#T3){ref-type="table"}\]. Among intraoperative characteristics, ketamine decreased the requirement of fentanyl in ketofol group as compared to the propofol group, and the difference was statistically significant (*P* = 0.022) \[[Table 3](#T3){ref-type="table"}\]. The addition of ketamine to propofol decreased the total requirement of propofol in ketofol group when compared to the propofol group, and the difference was statistically significant (*P* = 0.020) \[[Table 3](#T3){ref-type="table"}\]. In propofol group, 15 patients (75%) had ≥20% fall in MAP compared to five patients (25%) in ketofol group (*P* = 0.002). In propofol group, 11 patients (55%) required rescue drug phenylephrine to treat hypotension, whereas only three patients (15%) required it in ketofol group (*P* = 0.02) \[[Table 3](#T3){ref-type="table"}\]. Other intraoperative characteristics such as total intravenous fluids given, total urine output, anesthesia duration, and surgery duration were comparable in both groups \[[Table 3](#T3){ref-type="table"}\].

###### 

Intaoperative characterstics

  Parameters                                             KP (*n*=20)      P (*n*=20)       *P*
  ------------------------------------------------------ ---------------- ---------------- ----------
  Total fentanyl used (μg)/per patient                   271.9±29.8       307.15±35.6      0.022
  Total propofol used (mg)/per patient                   725.95±31.1      971±34.8         0.020
  Brain relaxation grade, 1/2/3/4                        2/13/5/0         3/12/5/0         0.887^π^
  MAP \>20% fall (number of patients), *n* (%)           5 (15)           15 (75)          0.002\*
  Phenylephrine required (number of patients), *n* (%)   3 (15)           11 (55)          0.020\*
  MAP \>20% rise (number of patients), *n* (%)           5 (25)           3 (15)           0.693
  Esmolol required (number of patients), *n* (%)         4 (20)           3 (15)           1.000
  Crystalloids (ml)                                      2282.5±246.128   2197.5±271.679   0.306^β^
  Urine output (ml)                                      865±202.029      854±123.391      0.836^β^
  Anesthesia time (min)                                  186.75±20.15     185.75±19.49     0.874^β^
  Surgery time (min)                                     157.25±19.09     155.75±19.89     0.809^β^

^π^Variables analyzed by Fisher's exact test, \**P* value \< 0.05 is considered significant, ^β^Variables analyzed by independent *t*-test, *P*\<0.05 was considered as statistically significant. KP=Ketofol, P=Propofol, MAP=Mean arterial pressure

Throughout the drug infusion period, MAP and H were better maintained, and hemodynamic fluctuations were less in patients receiving ketofol compared to those receiving propofol. Patients receiving propofol had a statistically significant lower recordings of H and MAP compared to those receiving ketofol (*P* \< 0.05) \[[Table 4](#T4){ref-type="table"}\].

###### 

Hemodynamic parameters

                                      MAP            Hemodynamic                                          
  ----------------------------------- -------------- ------------- ---------- ------------- ------------- ----------
  Preinduction                        103.25±5.17    100.60±5.42   0.122      80.95±4.55    81.10±3.04    0.903
  Baseline (prior to start of drug)   95.75±8.40     97.00±8.65    0.646      82.00±7.13    82.30±6.59    0.891
  Head pin application                102.85±6.18    102.55±6.67   0.883      89.75±5.93    89.05±6.43    0.722
  Burr hole                           98.20±7.08     67.90±4.17    0.0001\*   86.95±5.43    71.75±6.70    0.0001\*
  Starting craniotomy                 97.15±6.32     69.00±4.63    0.0001\*   89.40±6.18    69.40±4.41    0.0001\*
  Bone flap removal                   98.90±6.11     69.95±4.95    0.0001\*   88.15±3.53    69.80±5.63    0.0001\*
  Dural opening                       94.70±4.97     70.70±5.29    0.0001\*   83.80±7.37    69.00±6.29    0.0001\*
  Temporary clipping                  96.90±3.91     73.85±7.65    0.0001\*   74.75±7.54    77.20±8.43    0.339
  Permanent clipping                  90.85±6.30     71.10±4.52    0.0001\*   85.25±5.48    73.25±8.50    0.0001\*
  Dural closure                       99.65±7.08     76.20±7.89    0.0001\*   86.35±4.55    74.40±8.05    0.0001\*
  Muscle suture                       101.6±6.40     77.05±6.44    0.0001\*   85.30±4.69    71.90±7.31    0.0001\*
  Skin suture                         103.45±6.31    101.25±6.81   0.0001\*   83.70±6.32    83.20±8.22    0.830
  6 h postoperation                   107.00±10.84   99.71±12.20   0.0001\*   80.65±15.19   80.25±10.76   0.924

\**P* value \< 0.05 is considered significant. KP=Ketofol, P=Propofol, MAP=Mean arterial pressure

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Both intravenous, as well as inhalational agents, have been used for the maintenance of anesthesia during neurosurgery.\[[@ref10][@ref11][@ref12]\] Ketamine is less prevalent in neurosurgery because of its presumed adverse effects on cerebral hemodynamics.\[[@ref3][@ref13]\] The effects of each individual drug propofol and ketamine on cerebral oxygenation have been demonstrated in many studies; however, there is paucity in literature about the effects of ketofol on cerebral oxygenation. The present study is the first prospective randomized clinical trial which compares the effects of ketofol with propofol on cerebral oxygenation.

Jugular venous oxygen saturation {#sec2-2}
--------------------------------

We observed a statistically significant lower SjVO~2~ recording in patients who received propofol as compared to those who received ketofol at all-time points. It was statistically significant at 1-h, 2-h, and 6-h time points. Within the propofol group, the dip in SjVO~2~ at 2 h after starting the study drug infusion was significantly lower as compared to baseline (*P* = 0.001). We observed the lesser fall and lesser fluctuation in SjVO~2~ values in patients who received ketofol.

Similar to our study, many studies have shown that maintenance of anesthesia with propofol is associated with significantly lower levels of SjVO~2~ compared to inhalational anesthetic agents.\[[@ref8][@ref9][@ref14]\] Various studies had observed that there was no significant change in SjVO~2~ when different doses of ketamine was administered to patients who were on propofol sedation.\[[@ref8]\] Hence, results of our study with respect to effect of ketofol on SjVO~2~ is comparable with previous studies.

Propofol *per se* decreases the SjVO~2,~ and temporary clipping of parent aneurysmal vessel in our study could have aggravated this fall in SjVO~2~ in propofol group, thus explaining a significant fall in SjVO~2~ within the propofol group at 2 h after the start of test drug which usually coincides with temporary clipping time. The above observation of SjVO~2~ can be explained by the pharmacological action of ketamine. Sympathomimetic action of ketamine prevents the hypotension and bradycardia induced by propofol. Thus, a combination of ketamine and propofol maintains cerebral oxygenation.

Although there is a statistical difference in SjVO~2~ in between the groups, all the recordings of SjVO~2~ were within a normal range (50%--70%) in both the groups. The lowering of SjVO~2~ observed in propofol group may further risk the patients for cerebral ischemia, especially in patients vulnerable to insults such as prolonged temporary clipping, raised ICP, hypovolemia, and hemodynamic instability.

Bhardwaj *et al*.\[[@ref9]\] compared the effect of propofol and desflurane in SAH patients who underwent aneurysm clipping. Similar to our result, they observed lower values of SjVO~2~ in propofol group. However, the recordings were within a normal range (50%--70%) in either of the groups. Iwata *et al*.\[[@ref14]\] studied the effects of increasing concentration of propofol on jugular venous bulb oxygen saturation in neurosurgical patients under normothermic and mild hypothermic conditions. SjVO~2~ was measured at predicted propofol concentrations of 3, 5, and 7 μg/ml using a target-controlled infusion system in both groups. Although the authors concluded that under normothermic and hypothermic conditions, the increasing concentrations of propofol did not affect SjVO~2~ values in neurosurgical patients, there was a significant fall in SjVO~2~ (\<50%) at 3 μg/ml of propofol in normothermic patients (31% vs. 13%). Thus, under normothermic condition, the results are similar to our study.

Albanèse *et al*.\[[@ref8]\] analyzed the effect of intermittent doses of ketamine in traumatic brain injury patients who were receiving propofol sedation in ICU. They observed significant decrease in ICP and without any change in SjVO~2~ and CPP. Similarly, a study by Caricato *et al*.\[[@ref15]\] reported that no significant variation of SjVO~2~, MAP, CPP, and middle cerebral artery flow velocity were observed during endotracheal tube suctioning in traumatic brain injury patients sedated with propofol and remifentanil infusion, when ketamine infusion was added to prevent cough reflex during endotracheal suctioning. The study findings of ketamine are comparable with our study drug ketofol.

Brain relaxation {#sec2-3}
----------------

We found the quality of brain relaxation was similar in both the study groups (*P* = 0.887). Maximum number of patients had good brain condition in both the groups (grade II) \[[Figure 1](#F1){ref-type="fig"}\]. Many studies have shown that ICP reduction was more in intravenous anesthetics compared to inhalational anesthetics,\[[@ref16][@ref17][@ref18]\] but various anesthetic techniques have not shown any difference in brain relaxation.\[[@ref19]\] To the best of our knowledge, there is no study which has evaluated the effect of ketofol on brain relaxation.

![Brain relaxation grade](AER-13-643-g001){#F1}

Hemodynamic stability {#sec2-4}
---------------------

Heart rate (HR) and MAP recordings during test drug infusion were lower in propofol group as compared to ketofol group. Statistically significant lower MAP values were recorded at most of the time points in patients receiving propofol \[[Figure 2](#F2){ref-type="fig"}\].

![Mean arterial pressure](AER-13-643-g002){#F2}

In our study, fall in HR and MAP levels were more, and the hemodynamic fluctuations were higher in the propofol group as compared to ketofol. This observation can be explained by the sympathomimetic action of ketamine which alleviates the hypotension and bradycardia induced by propofol. A study by Aouad *et al*.\[[@ref20]\] conducted on pediatric patients undergoing procedural anesthesia, tried to evaluate the cumulative dose requirement of propofol/fentanyl as compared to ketofol/fentanyl. Similar to our study, they also concluded that better hemodynamic stability is achieved, and there is reduced consumption of propofol and fentanyl in patients receiving ketofol. This is due to analgesic property of ketamine which decreases the need for fentanyl/propofol in ketofol group.

A study from Smischney *et al*.\[[@ref21]\] witnessed a greater proportion of patients induced with propofol (48.8%) had fallen in MAP ≥20% from baseline value as compared to ketofol (12%). The author observed that improved hemodynamics during the first 10-min after induction was attained with ketofol as an induction agent. This effect of ketofol on hemodynamics during the first 10 min after induction is comparable to the present study observation during intraoperative period. Similar to our study, Sharma *et al*.\[[@ref22]\] observed better hemodynamic homeostasis along with optimum sedoanalgesia during TIVA with ketofol vis-à-vis propofol/fentanyl combination in minor orthopedic procedures.

Our study proposes the use of ketofol for the maintenance of anesthesia. This may alleviate the necessity for rescue vasopressors during the procedure and helps to maintain a better hemodynamic stability, thereby maintaining adequate cerebral perfusion and preventing cerebral ischemia. We have few limitations in this study. First, the monitoring of SjVO~2~ was not performed continuously. Hence, real-time correlation of SjVO~2~ with cerebral oxygenation could not be recorded. Second, the study cohort included only good grade aneurysms. Hence, the outcome of the study cannot be generalized to all grades of patients of SAH. Finally, the depth of anesthesia was titrated according to hemodynamics only and not by using any specialized monitoring like bispectral index, or entropy as ketamine is known to interfere with such monitoring and give inappropriate results.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

This study concludes that maintenance of anesthesia in patients undergoing clipping of aneurysm after SAH with ketofol provides better cerebral oxygenation and hemodynamic stability compared to propofol. There is no difference in quality of brain relaxation while using either ketofol or propofol. Therefore, ketofol is preferred over propofol as maintenance anesthetic agent in neurosurgical patients.
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